TargetTrack | Target Query Results

1 targets match your request

Target ID:JCSG-424890
Source Organism
Homo sapiens
Target Name
C.MS20865A
Target Category
community nominated
Target Rationale
Human proteins of medical relevance. Proposed by Dr. Michael Sundstrom, NNF Center for Protein Research, Copenhagen, Denmark.
Status
in PDB
Site
JCSG
Site ID
424890
Lab List
GNF,SSRL,UCSD
Structure available
4jon
Remark
Centrosomal protein 170kDa (CEP170), transcript variant beta, FHA domain, PF00498, putative protein-protein recognition
URL
http://www1.jcsg.org/...
Last Update
2013-03-18
Project List
PSI-3
Database References
GNF: NM_001042404, PSICNT: 208


Targets that contain a matching or similar sequence to your query are listed with the best alignments presented at the top. View the Alignment tab to see how closely a target sequence matches your query.

A target containing one or more sequences may have multiple alignments in this tab.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.